84 related articles for article (PubMed ID: 27802009)
1. Focal therapy in prostate cancer: A review of seven common controversies.
Bass EJ; Ahmed HU
Cancer Treat Rev; 2016 Dec; 51():27-34. PubMed ID: 27846402
[TBL] [Abstract][Full Text] [Related]
2. Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold.
Aprile C; Persico MG; Lodola L; Buroni FE
World J Radiol; 2016 Oct; 8(10):816-818. PubMed ID: 27843540
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy options in castration-resistant prostate cancer.
Teply BA; Hauke RJ
Indian J Urol; 2016; 32(4):262-270. PubMed ID: 27843207
[TBL] [Abstract][Full Text] [Related]
4. Sequencing Treatment for Castration-Resistant Prostate Cancer.
Handy CE; Antonarakis ES
Curr Treat Options Oncol; 2016 Dec; 17(12):64. PubMed ID: 27822685
[TBL] [Abstract][Full Text] [Related]
5. Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.
Burdett S; Boevé LM; Ingleby FC; Fisher DJ; Rydzewska LH; Vale CL; van Andel G; Clarke NW; Hulshof MC; James ND; Parker CC; Parmar MK; Sweeney CJ; Sydes MR; Tombal B; Verhagen PC; Tierney JF;
Eur Urol; 2019 Jul; 76(1):115-124. PubMed ID: 30826218
[TBL] [Abstract][Full Text] [Related]
6. The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer.
Xie J; Xiao X; Dong Z; Wang Q
J Inflamm Res; 2023; 16():963-975. PubMed ID: 36915616
[TBL] [Abstract][Full Text] [Related]
7. High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration.
Zhang Y; Ji Q; Wang J; Dong Y; Pang M; Fu S; Wei Y; Zhu Q
Front Genet; 2022; 13():1100787. PubMed ID: 36685823
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Local Therapy on M1c Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Wang Z; Cao D; Wei W
Front Surg; 2021; 8():648676. PubMed ID: 33968976
[No Abstract] [Full Text] [Related]
9. Impact of tumor cytoreduction in metastatic prostate cancer.
Sow Y; Sow O; Fall B; Sine B; Sarr A; Zé Ondo C; Diao B; Ndoye AK; Ba M
Res Rep Urol; 2019; 11():137-142. PubMed ID: 31192170
[No Abstract] [Full Text] [Related]
10. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
11. Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status.
Wu J; Lin G; Zhu Y; Zhang H; Shi G; Shen Y; Zhu Y; Dai B; Ye D
Sci Rep; 2017 Aug; 7(1):8869. PubMed ID: 28827755
[TBL] [Abstract][Full Text] [Related]
12. Local Therapy Improves Survival in Metastatic Prostate Cancer.
Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
[TBL] [Abstract][Full Text] [Related]
13. Impact of Radiotherapy on Prognosis in Patients Diagnosed with Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis.
Liu S; Wang XY; Huang TB; Ma XX; Xia ZZ; Tang LB; Zhao TS; Zhou GC
Urol Int; 2021; 105(5-6):370-379. PubMed ID: 33302278
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis.
Löppenberg B; Dalela D; Karabon P; Sood A; Sammon JD; Meyer CP; Sun M; Noldus J; Peabody JO; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 Jul; 72(1):14-19. PubMed ID: 27174537
[TBL] [Abstract][Full Text] [Related]
15. The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis.
Wang Y; Qin Z; Wang Y; Chen C; Wang Y; Meng X; Song N
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263146
[TBL] [Abstract][Full Text] [Related]
16. Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Tucci M; Bertaglia V; Vignani F; Buttigliero C; Fiori C; Porpiglia F; Scagliotti GV; Di Maio M
Eur Urol; 2016 Apr; 69(4):563-573. PubMed ID: 26422676
[TBL] [Abstract][Full Text] [Related]
17. Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis.
Carneiro A; Baccaglini W; Glina FPA; Kayano PP; Nunes VM; Smaletz O; Bernardo WM; Carvalho IT; Lemos GC
Int Braz J Urol; 2017; 43(4):588-599. PubMed ID: 27802009
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
